Jubilant Organosys is a collaborative, innovative provider of products and services to the global life sciences industry, striving to accelerate the process of pharmaceutical drug approval.

We have a presence across the pharmaceuticals value chain ranging from drug discovery services, custom research and manufacturing services, advance intermediates and fine chemicals to active pharmaceutical ingredients, dosage forms and regulatory affairs services.

We also enjoy leadership in Industrial and Performance Products in India.

Jubilant Organosys Ltd. is an integrated pharmaceutical industry player, one of the largest custom research and manufacturing services (CRAMS) and drug discovery and development services companies out of India. The company has a presence across the pharmaceutical value chain for products and services such as proprietary products ,exclusive synthesis, active pharmaceutical ingredients, contract manufacturing of sterile injectables (liquids and lyophilized) products, non-steriles (ointments, creams and liquid) and radiopharmaceuticals, drug discovery services, medicinal chemistry services, clinical research services ,generic dosage forms and Health Care.

We are one of the largest Indian Custom Research and Manufacturing Services (CRAMS) and Drug Discovery Services companies and a leading active pharmaceuticals ingredients company in India.

We are a Science Active company with more than 25 years of chemistry knowledge in producing innovative products and processes by leveraging our R&D expertise, knowledge driven operations and global scale manufacturing capacities.

Jubilant Organosys has five subsidiary companies in India Jubilant Biosys Ltd. for discovery informatics and drug discovery services, Jubilant Chemsys Ltd. for medicinal chemistry, Clinsys Clinical Research Ltd. for clinical research and bio availability / bio equivalence studies, Jubilant First Trust Healthcare Ltd. for high quality healthcare services and Speciality Molecules Pvt. Ltd. for niche expertise in continuous Vapor Phase halogenations reaction.

We have a strong international presence with subsidiaries in Canada, USA, Belgium and China. Draxis Specialty Pharmaceuticals Inc., Canada has USFDA approved manufacturing facility and offers sterile products, non-sterile products and radiopharmaceuticals.